FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.

Zhang, Qingxiang; Chen, Zhiguo; Zhang, Kaili; Zhu, Jie; Jin, Tao

Zhang, Qingxiang; Chen, Zhiguo; Zhang, Kaili; Zhu, Jie; Jin, Tao.

Afiliación

Zhang Q; Neuroscience Center, Department of Neurology, The First Hospital of Jilin University, Changchun, China.
Chen Z; Cell Therapy Center, Beijing Institute of Geriatrics, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
Zhang K; Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.
Zhu J; Stomatology College of Inner Mongolia Medical University, Hohhot, China.
Jin T; Neuroscience Center, Department of Neurology, The First Hospital of Jilin University, Changchun, China.

CNS Neurosci Ther ; 29(6): 1497-1511, 2023 06.

Article en En | MEDLINE | ID: mdl-36924298

Asunto(s)

Esclerosis Múltiple; Animales; Esclerosis Múltiple/metabolismo; Oligodendroglía/metabolismo; Factores de Crecimiento de Fibroblastos/metabolismo; Diferenciación Celular; Sistema Nervioso Central/metabolismo

Palabras clave

fibroblast growth factor receptors; fibroblast growth factors; inflammation; multiple sclerosis; remyelination

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: CNS Neurosci Ther Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google